🇺🇸 FDA
Patent

US 9717742

Oxysterol analogue OXY133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis

granted A61KA61K31/575A61K35/32

Quick answer

US patent 9717742 (Oxysterol analogue OXY133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis) held by The Regents of the University of California expires Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/575, A61K35/32, A61K38/1841, A61K38/1875